(Q40509949)
Statements
Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma (English)
Leo I Gordon
Thomas Witzig
Arturo Molina
Myron Czuczman
Christos Emmanouilides
Robin Joyce
Katie Vo
Charles Theuer
Brad Pohlman
Greg Wiseman
Mohamed Darif